Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Story Archive

  • Stem-Cell Gamble

    After years of controversy, a therapy based on human embryonic stem cells is finally being tested in humans. The treatment holds out hope to paralyzed people, but at how great a risk?

    16 comments

  • Material World

    The future availability and cost of important emerging ­technologies could depend on access to a handful of critical elements.

    1 comment

  • Measured Progress

    Apps to track the health of individuals are most powerful when we use them collectively.

  • Nuclear Lessons

    The Chernobyl and Fukushima nuclear accidents were failures of culture as well as technology.

  • Fragile Steps

    The dreams of millions ride on trials for a treatment that could allow the paralyzed to walk.

  • Nicholas Stern

    The World Bank’s former top economist took heat when he called for huge investments to head off climate change. Now he says he underestimated how much is needed.

    5 comments

  • The Perfect Scam

    It’s the dark side of innovation: how crooks peddling fake antivirus software have gamed the Web in a billion-dollar rip-off.

    10 comments

Pages

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me